Delivery Order SPE2DB22D3011-SPE2DB25FP8LJ

Award Date 1/7/25
Potential Completion Date 1/8/25
Potential Value $21K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Taltz 80mg/mL autoinjectors. The award, valued at $23,454.09, is a firm fixed-price contract with an ultimate completion date of August 28, 2024. This order is placed under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, worth up to $999,999,999 through December 2025, for the...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $24,829.43, is for the supply of Taltz 80 mg/ml autoinjector medication. The contract is a firm fixed-price delivery order, with an ultimate completion date of October 29, 2024. It is not designated as a set-aside contract, indicating open competition. AmerisourceBergen holds a significant...
The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price Delivery Order contract worth $4,188.24 to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Taltz 80 mg/ml autoinjectors. This order is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. The IDC enables DLA to efficiently procure a comprehensive range of pharmaceutical products...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $19,650.42, is for the supply of Taltz 80 mg/mL autoinjectors. The contract has a firm fixed price pricing type and an ultimate completion date of June 4, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support...
This is a $20,893.73 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The award is for the supply of Taltz 80 mg/mL autoinjectors, a specialty medication. The contract has a period of performance through September 30, 2024 and is not set aside for any specific business type. AmerisourceBergen holds several Indefinite Delivery Contracts (IDCs) with DLA and other federal agencies, valued up to...
This federal contract award, valued at $159,136.95, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Taltz 80 mg/mL autoinjectors, a specialty medication used to treat various medical conditions. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of December 27, 2024. It is not designated as a set-aside contract, indicating...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $9,555.39 firm fixed-price contract is for the delivery of Taltz 80 mg/mL autoinjectors, a specialty medication used to treat various medical conditions. The contract is associated with a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026....
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $58,992.76, is for the delivery of Taltz 80 mg/mL autoinjectors (2-pack) to support military healthcare programs. The contract is a Firm Fixed Price Delivery Order with a period of performance through December 31, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued at...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The order is for the pharmaceutical product Taltz 80 mg/mL autoinjector, with a ceiling value of $9,040.89 and a completion date of March 12, 2024. The contract does not have a set-aside designation. AmerisourceBergen Drug Corp is the prime contractor and has held numerous delivery orders with DLA Troop Support Medical to...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of Taltz 80 mg/mL autoinjectors. The total ceiling value of the award is $23,477.30, with a performance period through April 4, 2024. This delivery order is placed against an Indefinite Delivery Contract (IDC) held by AmerisourceBergen Drug Corp, which has a potential value of up to...
  • SPE2DB22D3011
    Indefinite Delivery Contract
  • SPE2DB22D3011-SPE2DB25FP8LJ
    Delivery Order

This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Taltz 80 mg/mL autoinjectors, a specialty medication, with a ceiling value of $20,729.98 and a period of performance through January 8, 2025.

The award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract encompasses critical medical commodities across multiple therapeutic domains.

This delivery order did not have a set-aside designation, indicating open competition. AmerisourceBergen is the prime contractor, and there is no mention of any major subcontractors. The DLA, a defense agency, is the funding agency for this award, which aligns with their role in supplying medical products to military treatment facilities, veterans' healthcare programs, and other federal medical institutions.

Generated 4/8/25, 9:43 AM